Pharmacy Benefits Management Services Home

PDE5 inhibitors are mild systemic vasodilators, hence SPEDRA may augment the blood pressure lowering effects of antihypertensive agents. A clinical study was conducted to assess the effect of SPEDRA on the potentiation of the blood pressurelowering effects of selected antihypertensive medications (amlodipine and enalapril). ................
................